{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-067504","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.734862+00:00","generated_at":"2026-06-18T05:29:30.137446+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Viridian Therapeutics discloses de minimis cash holdings at Silicon Valley Bank","bullets":["Company holds low single digit millions of USD in cash and equivalents at Silicon Valley Bank.","Disclosure made on March 10, 2023, amid SVB's collapse.","Amount is described as de minimis, indicating limited exposure.","Item 7.01 Regulation FD Disclosure filed with SEC as an 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-067504","json":"https://secwatch.observer/filing/0001193125-23-067504.json","markdown":"https://secwatch.observer/filing/0001193125-23-067504.md","text":"https://secwatch.observer/filing/0001193125-23-067504.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312523067504/0001193125-23-067504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312523067504/d354375d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:29:30.137446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}